In a research note issued today, Canaccord analyst David Tyerman maintained a Hold rating on Canadian Pacific Railway Limited (CP) with a price target of $182.00, given the lack of …
In a research note published Friday, Canaccord analyst Jason Mills maintained a Buy rating on Thoratec Corp. (THOR) with a price target of $37.
In a research report issued Friday, Canaccord analyst Camilo Lyon reiterated a Hold rating on shares of Nike, Inc. (NKE) and increased his price target to $76 (from $71) following Nike’s …
In a research report released Thursday, Canaccord analyst Corey Davis initiated coverage with a “Buy” rating on Endo International (ENDPׁׂ) and a price target of $83.00 a share, representing a potential upside of …
In a research note issued Thursday, Canaccord analyst Arun Melmane retained a Buy recommendation on Barclays PLC (BCS;BARC) withe a price target of 280p following yesterday’s news that the New York Attorney General’s office has …
In a research report issued Thursday, Canaccord analyst Corey Davis initiated coverage with a “Hold” rating on Teva Pharmaceutical Industries (TEVA) and a price target of $55.70 a share, based on the following: 1) valuation, …
In a research report released yesterday, Canaccord analyst Corey Davis initiated coverage with a “Buy” rating on Salix Pharmaceuticals (SLXP) and a price target of $145.00 a share, representing a potential upside of …
In a research report released today, Canaccord analyst Corey Davis initiated coverage with a “Buy” rating on Pacira Pharmaceuticals (PCRX) and a price target of $109.00 a share, representing a potential upside of …
In a research report issued Thursday, Canaccord analyst Corey Davis initiated coverage with a “Buy” rating on Actavis plc (ACT) and a price target of $275.00 a share, representing a potential …
In a research report issued yesterday, Canaccord analyst Laura Champine maintained a Hold rating on shares of Bed Bath & Beyond Inc. (BBBY) and a price target of $62.
